LANCET-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=500069, encodeId=93e65000697f, content=在上面投了篇letter，已经3个月了，还没给回复，不知道是好还是坏，期待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=447, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Nov 28 08:28:00 CST 2013, time=2013-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504712, encodeId=83e6504e12e5, content=那些发评论和通讯小豆腐的就不要吹牛了， 真心BS，谢谢读后感，搞个吧小病例， 人家一篇10分的article抵上你这种垃圾100篇。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=414, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Jul 30 16:18:00 CST 2014, time=2014-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2230440, encodeId=f6d5223044087, content=请问，lancet （correspondence）投稿后都会收到acknowledge吗？投稿一个月了，没有收到acknowledge，而且仍在with editor状态。有点不对头，时间太长了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34df6422310, createdName=ms8000000673612705, createdTime=Sat Oct 12 08:08:36 CST 2024, time=2024-10-12, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1225246, encodeId=0c241225246be, content=偏重的研究方向：肿瘤 经验分享：按照文章纸质版2周后编辑收稿算，我的评论型letter已经with editor3周了，不知道啥时出结果？好多说3周内接收的多。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1328, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/cef939b4dd64cf27ed24e16b17df7cf3.jpg, createdBy=a9282054067, createdName=Spider, createdTime=Wed Jun 08 18:00:42 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184922, encodeId=6a28118492291, content=审稿速度:1.0 经验分享：我来快乐地分享拒稿经验啦，投clinical picture，8天编辑部拒稿没送外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2909, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201229/b5a37848c84d49589914e316e825f6a6/20ac2d9c125d4d038df50793d67f65ef.jpg, createdBy=3fd35325265, createdName=17748b9278m, createdTime=Sun Jan 16 19:26:14 CST 2022, time=2022-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191745, encodeId=54911191e4574, content=偏重的研究方向：公共卫生;医学综合;糖尿病 经验分享：吓人！现在期刊分化会越来越严重，好的越来越好，差的越来越差, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1562, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/20220210/79fd17fcd5b741fcbb85b2243046243b.jpeg, type=image, width=514, height=162)], authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Thu Feb 10 11:03:32 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094625, encodeId=d0df109462568, content=SCI期刊是如何分区的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1246, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2121545, encodeId=9f9821215457e, content=偏重的研究方向：公共卫生 经验分享：投了一篇分析型的letter，不是评论，带点研究性质，已经一个月了，还是with editor，做决定好慢啊……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=536, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201104/e110baa6574e4220b15f12b12f7dc820/6b425004735845a2b3f1adb56a948307.jpg, createdBy=7ec95239393, createdName=采药者, createdTime=Fri Mar 24 11:01:25 CST 2023, time=2023-03-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2140243, encodeId=993e2140243c0, content=看看别人投稿的经验，自己学习一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=491, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ede62857934, createdName=4031828, createdTime=Thu Jun 01 07:01:28 CST 2023, time=2023-06-01, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2210798, encodeId=50362210e98f2, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：流行病学;综合期刊;医学综合 经验分享：NEJM在2023年度影响因子96.2，LANCET为98.4， BMJ为93.6，JAMA为63.1，表面看除JAMA外，三个名刊影响因子是差不多的，但是主要受前两年新冠相关文章的影响。到明年，BMJ和Lancet影响因子应该会较大幅度下降，但是JAMA和NEJM仍然能保持。NEJM仍然是行业老大，这个地位不会改变的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=246, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Thu Jun 20 13:55:29 CST 2024, time=2024-06-20, status=1, ipAttribution=伊利诺伊)]

2013-11-28 匿名用户

在上面投了篇letter，已经3个月了，还没给回复，不知道是好还是坏，期待中

447 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=500069, encodeId=93e65000697f, content=在上面投了篇letter，已经3个月了，还没给回复，不知道是好还是坏，期待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=447, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Nov 28 08:28:00 CST 2013, time=2013-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504712, encodeId=83e6504e12e5, content=那些发评论和通讯小豆腐的就不要吹牛了， 真心BS，谢谢读后感，搞个吧小病例， 人家一篇10分的article抵上你这种垃圾100篇。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=414, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Jul 30 16:18:00 CST 2014, time=2014-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2230440, encodeId=f6d5223044087, content=请问，lancet （correspondence）投稿后都会收到acknowledge吗？投稿一个月了，没有收到acknowledge，而且仍在with editor状态。有点不对头，时间太长了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34df6422310, createdName=ms8000000673612705, createdTime=Sat Oct 12 08:08:36 CST 2024, time=2024-10-12, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1225246, encodeId=0c241225246be, content=偏重的研究方向：肿瘤 经验分享：按照文章纸质版2周后编辑收稿算，我的评论型letter已经with editor3周了，不知道啥时出结果？好多说3周内接收的多。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1328, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/cef939b4dd64cf27ed24e16b17df7cf3.jpg, createdBy=a9282054067, createdName=Spider, createdTime=Wed Jun 08 18:00:42 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184922, encodeId=6a28118492291, content=审稿速度:1.0 经验分享：我来快乐地分享拒稿经验啦，投clinical picture，8天编辑部拒稿没送外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2909, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201229/b5a37848c84d49589914e316e825f6a6/20ac2d9c125d4d038df50793d67f65ef.jpg, createdBy=3fd35325265, createdName=17748b9278m, createdTime=Sun Jan 16 19:26:14 CST 2022, time=2022-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191745, encodeId=54911191e4574, content=偏重的研究方向：公共卫生;医学综合;糖尿病 经验分享：吓人！现在期刊分化会越来越严重，好的越来越好，差的越来越差, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1562, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/20220210/79fd17fcd5b741fcbb85b2243046243b.jpeg, type=image, width=514, height=162)], authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Thu Feb 10 11:03:32 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094625, encodeId=d0df109462568, content=SCI期刊是如何分区的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1246, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2121545, encodeId=9f9821215457e, content=偏重的研究方向：公共卫生 经验分享：投了一篇分析型的letter，不是评论，带点研究性质，已经一个月了，还是with editor，做决定好慢啊……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=536, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201104/e110baa6574e4220b15f12b12f7dc820/6b425004735845a2b3f1adb56a948307.jpg, createdBy=7ec95239393, createdName=采药者, createdTime=Fri Mar 24 11:01:25 CST 2023, time=2023-03-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2140243, encodeId=993e2140243c0, content=看看别人投稿的经验，自己学习一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=491, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ede62857934, createdName=4031828, createdTime=Thu Jun 01 07:01:28 CST 2023, time=2023-06-01, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2210798, encodeId=50362210e98f2, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：流行病学;综合期刊;医学综合 经验分享：NEJM在2023年度影响因子96.2，LANCET为98.4， BMJ为93.6，JAMA为63.1，表面看除JAMA外，三个名刊影响因子是差不多的，但是主要受前两年新冠相关文章的影响。到明年，BMJ和Lancet影响因子应该会较大幅度下降，但是JAMA和NEJM仍然能保持。NEJM仍然是行业老大，这个地位不会改变的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=246, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Thu Jun 20 13:55:29 CST 2024, time=2024-06-20, status=1, ipAttribution=伊利诺伊)]

2014-07-30 匿名用户

那些发评论和通讯小豆腐的就不要吹牛了，

真心BS，谢谢读后感，搞个吧小病例，

人家一篇10分的article抵上你这种垃圾100篇。

414 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=500069, encodeId=93e65000697f, content=在上面投了篇letter，已经3个月了，还没给回复，不知道是好还是坏，期待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=447, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Nov 28 08:28:00 CST 2013, time=2013-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504712, encodeId=83e6504e12e5, content=那些发评论和通讯小豆腐的就不要吹牛了， 真心BS，谢谢读后感，搞个吧小病例， 人家一篇10分的article抵上你这种垃圾100篇。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=414, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Jul 30 16:18:00 CST 2014, time=2014-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2230440, encodeId=f6d5223044087, content=请问，lancet （correspondence）投稿后都会收到acknowledge吗？投稿一个月了，没有收到acknowledge，而且仍在with editor状态。有点不对头，时间太长了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34df6422310, createdName=ms8000000673612705, createdTime=Sat Oct 12 08:08:36 CST 2024, time=2024-10-12, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1225246, encodeId=0c241225246be, content=偏重的研究方向：肿瘤 经验分享：按照文章纸质版2周后编辑收稿算，我的评论型letter已经with editor3周了，不知道啥时出结果？好多说3周内接收的多。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1328, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/cef939b4dd64cf27ed24e16b17df7cf3.jpg, createdBy=a9282054067, createdName=Spider, createdTime=Wed Jun 08 18:00:42 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184922, encodeId=6a28118492291, content=审稿速度:1.0 经验分享：我来快乐地分享拒稿经验啦，投clinical picture，8天编辑部拒稿没送外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2909, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201229/b5a37848c84d49589914e316e825f6a6/20ac2d9c125d4d038df50793d67f65ef.jpg, createdBy=3fd35325265, createdName=17748b9278m, createdTime=Sun Jan 16 19:26:14 CST 2022, time=2022-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191745, encodeId=54911191e4574, content=偏重的研究方向：公共卫生;医学综合;糖尿病 经验分享：吓人！现在期刊分化会越来越严重，好的越来越好，差的越来越差, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1562, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/20220210/79fd17fcd5b741fcbb85b2243046243b.jpeg, type=image, width=514, height=162)], authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Thu Feb 10 11:03:32 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094625, encodeId=d0df109462568, content=SCI期刊是如何分区的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1246, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2121545, encodeId=9f9821215457e, content=偏重的研究方向：公共卫生 经验分享：投了一篇分析型的letter，不是评论，带点研究性质，已经一个月了，还是with editor，做决定好慢啊……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=536, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201104/e110baa6574e4220b15f12b12f7dc820/6b425004735845a2b3f1adb56a948307.jpg, createdBy=7ec95239393, createdName=采药者, createdTime=Fri Mar 24 11:01:25 CST 2023, time=2023-03-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2140243, encodeId=993e2140243c0, content=看看别人投稿的经验，自己学习一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=491, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ede62857934, createdName=4031828, createdTime=Thu Jun 01 07:01:28 CST 2023, time=2023-06-01, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2210798, encodeId=50362210e98f2, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：流行病学;综合期刊;医学综合 经验分享：NEJM在2023年度影响因子96.2，LANCET为98.4， BMJ为93.6，JAMA为63.1，表面看除JAMA外，三个名刊影响因子是差不多的，但是主要受前两年新冠相关文章的影响。到明年，BMJ和Lancet影响因子应该会较大幅度下降，但是JAMA和NEJM仍然能保持。NEJM仍然是行业老大，这个地位不会改变的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=246, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Thu Jun 20 13:55:29 CST 2024, time=2024-06-20, status=1, ipAttribution=伊利诺伊)]

2024-10-12 ms8000000673612705 来自山东省

请问，lancet （correspondence）投稿后都会收到acknowledge吗？投稿一个月了，没有收到acknowledge，而且仍在with editor状态。有点不对头，时间太长了

99 0

[GetPortalCommentsPageByObjectIdResponse(id=500069, encodeId=93e65000697f, content=在上面投了篇letter，已经3个月了，还没给回复，不知道是好还是坏，期待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=447, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Nov 28 08:28:00 CST 2013, time=2013-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504712, encodeId=83e6504e12e5, content=那些发评论和通讯小豆腐的就不要吹牛了， 真心BS，谢谢读后感，搞个吧小病例， 人家一篇10分的article抵上你这种垃圾100篇。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=414, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Jul 30 16:18:00 CST 2014, time=2014-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2230440, encodeId=f6d5223044087, content=请问，lancet （correspondence）投稿后都会收到acknowledge吗？投稿一个月了，没有收到acknowledge，而且仍在with editor状态。有点不对头，时间太长了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34df6422310, createdName=ms8000000673612705, createdTime=Sat Oct 12 08:08:36 CST 2024, time=2024-10-12, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1225246, encodeId=0c241225246be, content=偏重的研究方向：肿瘤 经验分享：按照文章纸质版2周后编辑收稿算，我的评论型letter已经with editor3周了，不知道啥时出结果？好多说3周内接收的多。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1328, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/cef939b4dd64cf27ed24e16b17df7cf3.jpg, createdBy=a9282054067, createdName=Spider, createdTime=Wed Jun 08 18:00:42 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184922, encodeId=6a28118492291, content=审稿速度:1.0 经验分享：我来快乐地分享拒稿经验啦，投clinical picture，8天编辑部拒稿没送外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2909, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201229/b5a37848c84d49589914e316e825f6a6/20ac2d9c125d4d038df50793d67f65ef.jpg, createdBy=3fd35325265, createdName=17748b9278m, createdTime=Sun Jan 16 19:26:14 CST 2022, time=2022-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191745, encodeId=54911191e4574, content=偏重的研究方向：公共卫生;医学综合;糖尿病 经验分享：吓人！现在期刊分化会越来越严重，好的越来越好，差的越来越差, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1562, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/20220210/79fd17fcd5b741fcbb85b2243046243b.jpeg, type=image, width=514, height=162)], authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Thu Feb 10 11:03:32 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094625, encodeId=d0df109462568, content=SCI期刊是如何分区的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1246, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2121545, encodeId=9f9821215457e, content=偏重的研究方向：公共卫生 经验分享：投了一篇分析型的letter，不是评论，带点研究性质，已经一个月了，还是with editor，做决定好慢啊……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=536, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201104/e110baa6574e4220b15f12b12f7dc820/6b425004735845a2b3f1adb56a948307.jpg, createdBy=7ec95239393, createdName=采药者, createdTime=Fri Mar 24 11:01:25 CST 2023, time=2023-03-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2140243, encodeId=993e2140243c0, content=看看别人投稿的经验，自己学习一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=491, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ede62857934, createdName=4031828, createdTime=Thu Jun 01 07:01:28 CST 2023, time=2023-06-01, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2210798, encodeId=50362210e98f2, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：流行病学;综合期刊;医学综合 经验分享：NEJM在2023年度影响因子96.2，LANCET为98.4， BMJ为93.6，JAMA为63.1，表面看除JAMA外，三个名刊影响因子是差不多的，但是主要受前两年新冠相关文章的影响。到明年，BMJ和Lancet影响因子应该会较大幅度下降，但是JAMA和NEJM仍然能保持。NEJM仍然是行业老大，这个地位不会改变的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=246, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Thu Jun 20 13:55:29 CST 2024, time=2024-06-20, status=1, ipAttribution=伊利诺伊)]

2022-06-08 Spider

偏重的研究方向：肿瘤
经验分享：按照文章纸质版2周后编辑收稿算，我的评论型letter已经with editor3周了，不知道啥时出结果？好多说3周内接收的多。。。

1328 17

展开17条回复

[GetPortalCommentsPageByObjectIdResponse(id=500069, encodeId=93e65000697f, content=在上面投了篇letter，已经3个月了，还没给回复，不知道是好还是坏，期待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=447, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Nov 28 08:28:00 CST 2013, time=2013-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504712, encodeId=83e6504e12e5, content=那些发评论和通讯小豆腐的就不要吹牛了， 真心BS，谢谢读后感，搞个吧小病例， 人家一篇10分的article抵上你这种垃圾100篇。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=414, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Jul 30 16:18:00 CST 2014, time=2014-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2230440, encodeId=f6d5223044087, content=请问，lancet （correspondence）投稿后都会收到acknowledge吗？投稿一个月了，没有收到acknowledge，而且仍在with editor状态。有点不对头，时间太长了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34df6422310, createdName=ms8000000673612705, createdTime=Sat Oct 12 08:08:36 CST 2024, time=2024-10-12, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1225246, encodeId=0c241225246be, content=偏重的研究方向：肿瘤 经验分享：按照文章纸质版2周后编辑收稿算，我的评论型letter已经with editor3周了，不知道啥时出结果？好多说3周内接收的多。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1328, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/cef939b4dd64cf27ed24e16b17df7cf3.jpg, createdBy=a9282054067, createdName=Spider, createdTime=Wed Jun 08 18:00:42 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184922, encodeId=6a28118492291, content=审稿速度:1.0 经验分享：我来快乐地分享拒稿经验啦，投clinical picture，8天编辑部拒稿没送外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2909, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201229/b5a37848c84d49589914e316e825f6a6/20ac2d9c125d4d038df50793d67f65ef.jpg, createdBy=3fd35325265, createdName=17748b9278m, createdTime=Sun Jan 16 19:26:14 CST 2022, time=2022-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191745, encodeId=54911191e4574, content=偏重的研究方向：公共卫生;医学综合;糖尿病 经验分享：吓人！现在期刊分化会越来越严重，好的越来越好，差的越来越差, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1562, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/20220210/79fd17fcd5b741fcbb85b2243046243b.jpeg, type=image, width=514, height=162)], authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Thu Feb 10 11:03:32 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094625, encodeId=d0df109462568, content=SCI期刊是如何分区的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1246, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2121545, encodeId=9f9821215457e, content=偏重的研究方向：公共卫生 经验分享：投了一篇分析型的letter，不是评论，带点研究性质，已经一个月了，还是with editor，做决定好慢啊……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=536, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201104/e110baa6574e4220b15f12b12f7dc820/6b425004735845a2b3f1adb56a948307.jpg, createdBy=7ec95239393, createdName=采药者, createdTime=Fri Mar 24 11:01:25 CST 2023, time=2023-03-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2140243, encodeId=993e2140243c0, content=看看别人投稿的经验，自己学习一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=491, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ede62857934, createdName=4031828, createdTime=Thu Jun 01 07:01:28 CST 2023, time=2023-06-01, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2210798, encodeId=50362210e98f2, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：流行病学;综合期刊;医学综合 经验分享：NEJM在2023年度影响因子96.2，LANCET为98.4， BMJ为93.6，JAMA为63.1，表面看除JAMA外，三个名刊影响因子是差不多的，但是主要受前两年新冠相关文章的影响。到明年，BMJ和Lancet影响因子应该会较大幅度下降，但是JAMA和NEJM仍然能保持。NEJM仍然是行业老大，这个地位不会改变的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=246, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Thu Jun 20 13:55:29 CST 2024, time=2024-06-20, status=1, ipAttribution=伊利诺伊)]

2022-01-16 17748b9278m

审稿速度:1.0
经验分享：我来快乐地分享拒稿经验啦，投clinical picture，8天编辑部拒稿没送外审

2909 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=500069, encodeId=93e65000697f, content=在上面投了篇letter，已经3个月了，还没给回复，不知道是好还是坏，期待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=447, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Nov 28 08:28:00 CST 2013, time=2013-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504712, encodeId=83e6504e12e5, content=那些发评论和通讯小豆腐的就不要吹牛了， 真心BS，谢谢读后感，搞个吧小病例， 人家一篇10分的article抵上你这种垃圾100篇。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=414, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Jul 30 16:18:00 CST 2014, time=2014-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2230440, encodeId=f6d5223044087, content=请问，lancet （correspondence）投稿后都会收到acknowledge吗？投稿一个月了，没有收到acknowledge，而且仍在with editor状态。有点不对头，时间太长了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34df6422310, createdName=ms8000000673612705, createdTime=Sat Oct 12 08:08:36 CST 2024, time=2024-10-12, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1225246, encodeId=0c241225246be, content=偏重的研究方向：肿瘤 经验分享：按照文章纸质版2周后编辑收稿算，我的评论型letter已经with editor3周了，不知道啥时出结果？好多说3周内接收的多。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1328, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/cef939b4dd64cf27ed24e16b17df7cf3.jpg, createdBy=a9282054067, createdName=Spider, createdTime=Wed Jun 08 18:00:42 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184922, encodeId=6a28118492291, content=审稿速度:1.0 经验分享：我来快乐地分享拒稿经验啦，投clinical picture，8天编辑部拒稿没送外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2909, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201229/b5a37848c84d49589914e316e825f6a6/20ac2d9c125d4d038df50793d67f65ef.jpg, createdBy=3fd35325265, createdName=17748b9278m, createdTime=Sun Jan 16 19:26:14 CST 2022, time=2022-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191745, encodeId=54911191e4574, content=偏重的研究方向：公共卫生;医学综合;糖尿病 经验分享：吓人！现在期刊分化会越来越严重，好的越来越好，差的越来越差, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1562, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/20220210/79fd17fcd5b741fcbb85b2243046243b.jpeg, type=image, width=514, height=162)], authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Thu Feb 10 11:03:32 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094625, encodeId=d0df109462568, content=SCI期刊是如何分区的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1246, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2121545, encodeId=9f9821215457e, content=偏重的研究方向：公共卫生 经验分享：投了一篇分析型的letter，不是评论，带点研究性质，已经一个月了，还是with editor，做决定好慢啊……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=536, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201104/e110baa6574e4220b15f12b12f7dc820/6b425004735845a2b3f1adb56a948307.jpg, createdBy=7ec95239393, createdName=采药者, createdTime=Fri Mar 24 11:01:25 CST 2023, time=2023-03-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2140243, encodeId=993e2140243c0, content=看看别人投稿的经验，自己学习一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=491, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ede62857934, createdName=4031828, createdTime=Thu Jun 01 07:01:28 CST 2023, time=2023-06-01, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2210798, encodeId=50362210e98f2, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：流行病学;综合期刊;医学综合 经验分享：NEJM在2023年度影响因子96.2，LANCET为98.4， BMJ为93.6，JAMA为63.1，表面看除JAMA外，三个名刊影响因子是差不多的，但是主要受前两年新冠相关文章的影响。到明年，BMJ和Lancet影响因子应该会较大幅度下降，但是JAMA和NEJM仍然能保持。NEJM仍然是行业老大，这个地位不会改变的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=246, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Thu Jun 20 13:55:29 CST 2024, time=2024-06-20, status=1, ipAttribution=伊利诺伊)]

2022-02-10 医者仁者

精彩评论，需要您登录查看

1562 5

[GetPortalCommentsPageByObjectIdResponse(id=500069, encodeId=93e65000697f, content=在上面投了篇letter，已经3个月了，还没给回复，不知道是好还是坏，期待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=447, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Nov 28 08:28:00 CST 2013, time=2013-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504712, encodeId=83e6504e12e5, content=那些发评论和通讯小豆腐的就不要吹牛了， 真心BS，谢谢读后感，搞个吧小病例， 人家一篇10分的article抵上你这种垃圾100篇。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=414, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Jul 30 16:18:00 CST 2014, time=2014-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2230440, encodeId=f6d5223044087, content=请问，lancet （correspondence）投稿后都会收到acknowledge吗？投稿一个月了，没有收到acknowledge，而且仍在with editor状态。有点不对头，时间太长了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34df6422310, createdName=ms8000000673612705, createdTime=Sat Oct 12 08:08:36 CST 2024, time=2024-10-12, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1225246, encodeId=0c241225246be, content=偏重的研究方向：肿瘤 经验分享：按照文章纸质版2周后编辑收稿算，我的评论型letter已经with editor3周了，不知道啥时出结果？好多说3周内接收的多。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1328, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/cef939b4dd64cf27ed24e16b17df7cf3.jpg, createdBy=a9282054067, createdName=Spider, createdTime=Wed Jun 08 18:00:42 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184922, encodeId=6a28118492291, content=审稿速度:1.0 经验分享：我来快乐地分享拒稿经验啦，投clinical picture，8天编辑部拒稿没送外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2909, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201229/b5a37848c84d49589914e316e825f6a6/20ac2d9c125d4d038df50793d67f65ef.jpg, createdBy=3fd35325265, createdName=17748b9278m, createdTime=Sun Jan 16 19:26:14 CST 2022, time=2022-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191745, encodeId=54911191e4574, content=偏重的研究方向：公共卫生;医学综合;糖尿病 经验分享：吓人！现在期刊分化会越来越严重，好的越来越好，差的越来越差, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1562, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/20220210/79fd17fcd5b741fcbb85b2243046243b.jpeg, type=image, width=514, height=162)], authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Thu Feb 10 11:03:32 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094625, encodeId=d0df109462568, content=SCI期刊是如何分区的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1246, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2121545, encodeId=9f9821215457e, content=偏重的研究方向：公共卫生 经验分享：投了一篇分析型的letter，不是评论，带点研究性质，已经一个月了，还是with editor，做决定好慢啊……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=536, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201104/e110baa6574e4220b15f12b12f7dc820/6b425004735845a2b3f1adb56a948307.jpg, createdBy=7ec95239393, createdName=采药者, createdTime=Fri Mar 24 11:01:25 CST 2023, time=2023-03-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2140243, encodeId=993e2140243c0, content=看看别人投稿的经验，自己学习一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=491, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ede62857934, createdName=4031828, createdTime=Thu Jun 01 07:01:28 CST 2023, time=2023-06-01, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2210798, encodeId=50362210e98f2, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：流行病学;综合期刊;医学综合 经验分享：NEJM在2023年度影响因子96.2，LANCET为98.4， BMJ为93.6，JAMA为63.1，表面看除JAMA外，三个名刊影响因子是差不多的，但是主要受前两年新冠相关文章的影响。到明年，BMJ和Lancet影响因子应该会较大幅度下降，但是JAMA和NEJM仍然能保持。NEJM仍然是行业老大，这个地位不会改变的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=246, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Thu Jun 20 13:55:29 CST 2024, time=2024-06-20, status=1, ipAttribution=伊利诺伊)]

2021-12-29 衣谷

SCI期刊是如何分区的？

1246 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=500069, encodeId=93e65000697f, content=在上面投了篇letter，已经3个月了，还没给回复，不知道是好还是坏，期待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=447, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Nov 28 08:28:00 CST 2013, time=2013-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504712, encodeId=83e6504e12e5, content=那些发评论和通讯小豆腐的就不要吹牛了， 真心BS，谢谢读后感，搞个吧小病例， 人家一篇10分的article抵上你这种垃圾100篇。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=414, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Jul 30 16:18:00 CST 2014, time=2014-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2230440, encodeId=f6d5223044087, content=请问，lancet （correspondence）投稿后都会收到acknowledge吗？投稿一个月了，没有收到acknowledge，而且仍在with editor状态。有点不对头，时间太长了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34df6422310, createdName=ms8000000673612705, createdTime=Sat Oct 12 08:08:36 CST 2024, time=2024-10-12, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1225246, encodeId=0c241225246be, content=偏重的研究方向：肿瘤 经验分享：按照文章纸质版2周后编辑收稿算，我的评论型letter已经with editor3周了，不知道啥时出结果？好多说3周内接收的多。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1328, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/cef939b4dd64cf27ed24e16b17df7cf3.jpg, createdBy=a9282054067, createdName=Spider, createdTime=Wed Jun 08 18:00:42 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184922, encodeId=6a28118492291, content=审稿速度:1.0 经验分享：我来快乐地分享拒稿经验啦，投clinical picture，8天编辑部拒稿没送外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2909, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201229/b5a37848c84d49589914e316e825f6a6/20ac2d9c125d4d038df50793d67f65ef.jpg, createdBy=3fd35325265, createdName=17748b9278m, createdTime=Sun Jan 16 19:26:14 CST 2022, time=2022-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191745, encodeId=54911191e4574, content=偏重的研究方向：公共卫生;医学综合;糖尿病 经验分享：吓人！现在期刊分化会越来越严重，好的越来越好，差的越来越差, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1562, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/20220210/79fd17fcd5b741fcbb85b2243046243b.jpeg, type=image, width=514, height=162)], authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Thu Feb 10 11:03:32 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094625, encodeId=d0df109462568, content=SCI期刊是如何分区的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1246, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2121545, encodeId=9f9821215457e, content=偏重的研究方向：公共卫生 经验分享：投了一篇分析型的letter，不是评论，带点研究性质，已经一个月了，还是with editor，做决定好慢啊……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=536, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201104/e110baa6574e4220b15f12b12f7dc820/6b425004735845a2b3f1adb56a948307.jpg, createdBy=7ec95239393, createdName=采药者, createdTime=Fri Mar 24 11:01:25 CST 2023, time=2023-03-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2140243, encodeId=993e2140243c0, content=看看别人投稿的经验，自己学习一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=491, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ede62857934, createdName=4031828, createdTime=Thu Jun 01 07:01:28 CST 2023, time=2023-06-01, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2210798, encodeId=50362210e98f2, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：流行病学;综合期刊;医学综合 经验分享：NEJM在2023年度影响因子96.2，LANCET为98.4， BMJ为93.6，JAMA为63.1，表面看除JAMA外，三个名刊影响因子是差不多的，但是主要受前两年新冠相关文章的影响。到明年，BMJ和Lancet影响因子应该会较大幅度下降，但是JAMA和NEJM仍然能保持。NEJM仍然是行业老大，这个地位不会改变的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=246, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Thu Jun 20 13:55:29 CST 2024, time=2024-06-20, status=1, ipAttribution=伊利诺伊)]

2023-03-24 采药者来自广东省

偏重的研究方向：公共卫生
经验分享：投了一篇分析型的letter，不是评论，带点研究性质，已经一个月了，还是with editor，做决定好慢啊……

536 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=500069, encodeId=93e65000697f, content=在上面投了篇letter，已经3个月了，还没给回复，不知道是好还是坏，期待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=447, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Nov 28 08:28:00 CST 2013, time=2013-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504712, encodeId=83e6504e12e5, content=那些发评论和通讯小豆腐的就不要吹牛了， 真心BS，谢谢读后感，搞个吧小病例， 人家一篇10分的article抵上你这种垃圾100篇。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=414, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Jul 30 16:18:00 CST 2014, time=2014-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2230440, encodeId=f6d5223044087, content=请问，lancet （correspondence）投稿后都会收到acknowledge吗？投稿一个月了，没有收到acknowledge，而且仍在with editor状态。有点不对头，时间太长了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34df6422310, createdName=ms8000000673612705, createdTime=Sat Oct 12 08:08:36 CST 2024, time=2024-10-12, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1225246, encodeId=0c241225246be, content=偏重的研究方向：肿瘤 经验分享：按照文章纸质版2周后编辑收稿算，我的评论型letter已经with editor3周了，不知道啥时出结果？好多说3周内接收的多。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1328, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/cef939b4dd64cf27ed24e16b17df7cf3.jpg, createdBy=a9282054067, createdName=Spider, createdTime=Wed Jun 08 18:00:42 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184922, encodeId=6a28118492291, content=审稿速度:1.0 经验分享：我来快乐地分享拒稿经验啦，投clinical picture，8天编辑部拒稿没送外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2909, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201229/b5a37848c84d49589914e316e825f6a6/20ac2d9c125d4d038df50793d67f65ef.jpg, createdBy=3fd35325265, createdName=17748b9278m, createdTime=Sun Jan 16 19:26:14 CST 2022, time=2022-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191745, encodeId=54911191e4574, content=偏重的研究方向：公共卫生;医学综合;糖尿病 经验分享：吓人！现在期刊分化会越来越严重，好的越来越好，差的越来越差, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1562, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/20220210/79fd17fcd5b741fcbb85b2243046243b.jpeg, type=image, width=514, height=162)], authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Thu Feb 10 11:03:32 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094625, encodeId=d0df109462568, content=SCI期刊是如何分区的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1246, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2121545, encodeId=9f9821215457e, content=偏重的研究方向：公共卫生 经验分享：投了一篇分析型的letter，不是评论，带点研究性质，已经一个月了，还是with editor，做决定好慢啊……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=536, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201104/e110baa6574e4220b15f12b12f7dc820/6b425004735845a2b3f1adb56a948307.jpg, createdBy=7ec95239393, createdName=采药者, createdTime=Fri Mar 24 11:01:25 CST 2023, time=2023-03-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2140243, encodeId=993e2140243c0, content=看看别人投稿的经验，自己学习一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=491, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ede62857934, createdName=4031828, createdTime=Thu Jun 01 07:01:28 CST 2023, time=2023-06-01, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2210798, encodeId=50362210e98f2, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：流行病学;综合期刊;医学综合 经验分享：NEJM在2023年度影响因子96.2，LANCET为98.4， BMJ为93.6，JAMA为63.1，表面看除JAMA外，三个名刊影响因子是差不多的，但是主要受前两年新冠相关文章的影响。到明年，BMJ和Lancet影响因子应该会较大幅度下降，但是JAMA和NEJM仍然能保持。NEJM仍然是行业老大，这个地位不会改变的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=246, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Thu Jun 20 13:55:29 CST 2024, time=2024-06-20, status=1, ipAttribution=伊利诺伊)]

2023-06-01 4031828 来自河南省

看看别人投稿的经验，自己学习一下

491 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=500069, encodeId=93e65000697f, content=在上面投了篇letter，已经3个月了，还没给回复，不知道是好还是坏，期待中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=447, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Nov 28 08:28:00 CST 2013, time=2013-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504712, encodeId=83e6504e12e5, content=那些发评论和通讯小豆腐的就不要吹牛了， 真心BS，谢谢读后感，搞个吧小病例， 人家一篇10分的article抵上你这种垃圾100篇。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=414, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Jul 30 16:18:00 CST 2014, time=2014-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2230440, encodeId=f6d5223044087, content=请问，lancet （correspondence）投稿后都会收到acknowledge吗？投稿一个月了，没有收到acknowledge，而且仍在with editor状态。有点不对头，时间太长了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34df6422310, createdName=ms8000000673612705, createdTime=Sat Oct 12 08:08:36 CST 2024, time=2024-10-12, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1225246, encodeId=0c241225246be, content=偏重的研究方向：肿瘤 经验分享：按照文章纸质版2周后编辑收稿算，我的评论型letter已经with editor3周了，不知道啥时出结果？好多说3周内接收的多。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1328, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/cef939b4dd64cf27ed24e16b17df7cf3.jpg, createdBy=a9282054067, createdName=Spider, createdTime=Wed Jun 08 18:00:42 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184922, encodeId=6a28118492291, content=审稿速度:1.0 经验分享：我来快乐地分享拒稿经验啦，投clinical picture，8天编辑部拒稿没送外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2909, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201229/b5a37848c84d49589914e316e825f6a6/20ac2d9c125d4d038df50793d67f65ef.jpg, createdBy=3fd35325265, createdName=17748b9278m, createdTime=Sun Jan 16 19:26:14 CST 2022, time=2022-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191745, encodeId=54911191e4574, content=偏重的研究方向：公共卫生;医学综合;糖尿病 经验分享：吓人！现在期刊分化会越来越严重，好的越来越好，差的越来越差, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1562, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/20220210/79fd17fcd5b741fcbb85b2243046243b.jpeg, type=image, width=514, height=162)], authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Thu Feb 10 11:03:32 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094625, encodeId=d0df109462568, content=SCI期刊是如何分区的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1246, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2121545, encodeId=9f9821215457e, content=偏重的研究方向：公共卫生 经验分享：投了一篇分析型的letter，不是评论，带点研究性质，已经一个月了，还是with editor，做决定好慢啊……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=536, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201104/e110baa6574e4220b15f12b12f7dc820/6b425004735845a2b3f1adb56a948307.jpg, createdBy=7ec95239393, createdName=采药者, createdTime=Fri Mar 24 11:01:25 CST 2023, time=2023-03-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2140243, encodeId=993e2140243c0, content=看看别人投稿的经验，自己学习一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=491, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ede62857934, createdName=4031828, createdTime=Thu Jun 01 07:01:28 CST 2023, time=2023-06-01, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2210798, encodeId=50362210e98f2, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：流行病学;综合期刊;医学综合 经验分享：NEJM在2023年度影响因子96.2，LANCET为98.4， BMJ为93.6，JAMA为63.1，表面看除JAMA外，三个名刊影响因子是差不多的，但是主要受前两年新冠相关文章的影响。到明年，BMJ和Lancet影响因子应该会较大幅度下降，但是JAMA和NEJM仍然能保持。NEJM仍然是行业老大，这个地位不会改变的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=246, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Thu Jun 20 13:55:29 CST 2024, time=2024-06-20, status=1, ipAttribution=伊利诺伊)]

2024-06-20 侠胆医心来自伊利诺伊

审稿速度:3.0 | 投稿命中率:25.0
偏重的研究方向：流行病学;综合期刊;医学综合
经验分享：NEJM在2023年度影响因子96.2，LANCET为98.4， BMJ为93.6，JAMA为63.1，表面看除JAMA外，三个名刊影响因子是差不多的，但是主要受前两年新冠相关文章的影响。到明年，BMJ和Lancet影响因子应该会较大幅度下降，但是JAMA和NEJM仍然能保持。NEJM仍然是行业老大，这个地位不会改变的。

246 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务